Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Unit to Distribute LifeTech's SeCore HLA Typing Kits

NEW YORK (GenomeWeb News) – Gen-Probe said today that it has inked an agreement to distribute Life Technologies' SeCore Human Leukocyte Antigen Sequence-Based Typing kits for use with the 3500 Dx Genetic Analyzer.

Under the agreement, Gen-Probe's LifeCodes business unit will have co-exclusive rights to sell the SeCore SBT line in the transplant market alongside Life Technologies' HLA sales force in the US.

Gen-Probe said LifeCodes plans to begin selling the SeCore HLA SBT line this month. The line is cleared for research use only, the company said, and not for diagnostic purposes.

Gen-Probe said that the distribution agreement follows on a supply and collaboration pact signed between the companies last year, under which Gen-Probe gained the rights to commercialize tests based on sequencing and fragment analysis to run on Life Tech's 3500 Dx Genetic Analyzer.

"With the growing importance of sequencing in transplant diagnostics, the SeCore HLA SBT product line will play a significant role in future growth by rounding out our product portfolio with one of the highest resolution offerings in molecular typing," LifeCodes GM Shawn Marcell said in a statement.

"This relationship was established to offer customers greater flexibility and access to high-resolution typing solutions with efficient workflows," added Todd Laird, GM of Life Technologies' transplant business.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.